Table 1.

Clinical studies, types of renal disease, and treatment in Waldenström's macroglobulinemia.

Study	Number of patients	Pathology seen	Treatment
Morel-Maroger et al. [2]	16 patients	3 amyloidosis 6 nonamyloid glomerular disease (3 cryoglobulinemia) 7 had no detectable lesions	Not available
Higgins et al. [1]	44 patients	17 amyloidosis 9 nonamyloid glomerular disease 7 tubulointerstitial nephritis 9 non-monoclonal gammopathy-related glomerular disease (1FSGS)	Amyloid glomerulopathy: Rituximab R Ituximab Chemotherapy Bortezomib Nonamyloid glomerulopathy: Steroid Rituximab Rituxima Bendamustine Bortezomib Chemotherapy
Vos et al. [3]	44 patients	Amyloidosis 11 Cryoglobulinemia 10 Light-chain deposition disease 4 Cast nephropathy 4 TMA 3 Minimal change disease 2 Membranous nephropathy 1 LPL infiltration 8 Light-chain tubulopathy 1	Proteosome inhibitor + rituximab Alkylator + rituximab Nucleoside analogue + rituximab Bendamustine Single-agent rituximab

LPL: lymphoplasmacytic lymphoma infiltration; TMA: thrombotic microangiopathy.